CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
267.21M
SBHMY
Price
$20.16
Change
+$0.66 (+3.38%)
Updated
Aug 27 closing price
Capitalization
20.43B
Interact to see
Advertisement

CMVLF vs SBHMY

Header iconCMVLF vs SBHMY Comparison
Open Charts CMVLF vs SBHMYBanner chart's image
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization267.21M
Sino Biopharmaceutical
Price$20.16
Change+$0.66 (+3.38%)
Volume$264
Capitalization20.43B
CMVLF vs SBHMY Comparison Chart in %
Loading...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMVLF vs. SBHMY commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMVLF is a Hold and SBHMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CMVLF: $2.60 vs. SBHMY: $20.03)
Brand notoriety: CMVLF and SBHMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMVLF: 72% vs. SBHMY: 43%
Market capitalization -- CMVLF: $267.21M vs. SBHMY: $20.43B
CMVLF [@Biotechnology] is valued at $267.21M. SBHMY’s [@Biotechnology] market capitalization is $20.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMVLF’s FA Score shows that 1 FA rating(s) are green whileSBHMY’s FA Score has 2 green FA rating(s).

  • CMVLF’s FA Score: 1 green, 4 red.
  • SBHMY’s FA Score: 2 green, 3 red.
According to our system of comparison, SBHMY is a better buy in the long-term than CMVLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMVLF’s TA Score shows that 3 TA indicator(s) are bullish while SBHMY’s TA Score has 1 bullish TA indicator(s).

  • CMVLF’s TA Score: 3 bullish, 2 bearish.
  • SBHMY’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, CMVLF is a better buy in the short-term than SBHMY.

Price Growth

CMVLF (@Biotechnology) experienced а -16.67% price change this week, while SBHMY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +33.07%.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($20.4B) has a higher market cap than CMVLF($267M). SBHMY YTD gains are higher at: 147.190 vs. CMVLF (73.333).
CMVLFSBHMYCMVLF / SBHMY
Capitalization267M20.4B1%
EBITDA-30.25MN/A-
Gain YTD73.333147.19050%
P/E RatioN/A33.29-
Revenue56.3MN/A-
Total Cash196MN/A-
Total Debt94.8MN/A-
FUNDAMENTALS RATINGS
CMVLF vs SBHMY: Fundamental Ratings
CMVLF
SBHMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
10024
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (3) in the null industry is in the same range as CMVLF (29). This means that SBHMY’s stock grew similarly to CMVLF’s over the last 12 months.

SBHMY's Profit vs Risk Rating (88) in the null industry is in the same range as CMVLF (100). This means that SBHMY’s stock grew similarly to CMVLF’s over the last 12 months.

SBHMY's SMR Rating (96) in the null industry is in the same range as CMVLF (98). This means that SBHMY’s stock grew similarly to CMVLF’s over the last 12 months.

SBHMY's Price Growth Rating (35) in the null industry is in the same range as CMVLF (38). This means that SBHMY’s stock grew similarly to CMVLF’s over the last 12 months.

SBHMY's P/E Growth Rating (24) in the null industry is significantly better than the same rating for CMVLF (100). This means that SBHMY’s stock grew significantly faster than CMVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMVLFSBHMY
RSI
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
35%
Bearish Trend 4 days ago
49%
Momentum
ODDS (%)
Bearish Trend 4 days ago
70%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
48%
Bearish Trend 4 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
67%
Bullish Trend 4 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
38%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
36%
Aroon
ODDS (%)
Bullish Trend 4 days ago
39%
Bullish Trend 4 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIP4.180.04
+0.97%
FTAI Infrastructure
TISI19.23-0.02
-0.10%
Team
EVTC34.47-0.13
-0.38%
EVERTEC
WF52.91-0.32
-0.60%
Woori Financial Group
AZTR0.86-0.02
-2.52%
Azitra

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been loosely correlated with TENX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CMVLF jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
TENX - CMVLF
56%
Loosely correlated
-0.08%
SBHMY - CMVLF
51%
Loosely correlated
N/A
AURA - CMVLF
30%
Poorly correlated
+0.93%
ALDX - CMVLF
23%
Poorly correlated
+0.54%
TARS - CMVLF
23%
Poorly correlated
+0.35%
More

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with CMVLF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
CMVLF - SBHMY
51%
Loosely correlated
N/A
SYBX - SBHMY
39%
Loosely correlated
N/A
BTAI - SBHMY
32%
Poorly correlated
+6.16%
TENX - SBHMY
27%
Poorly correlated
-0.08%
SPHRF - SBHMY
24%
Poorly correlated
N/A
More